DR. WILLIAM MICHAEL KAVANAUGH, M.D.
Osteopathic Medicine at Clement St, San Francisco, CA
License number
California G53774
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California G53774
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
2
4150 Clement St DEPARTMENT 111C, San Francisco, CA 94121
77 Orchard Rd, Orinda, CA 94563
77 Orchard Rd, Orinda, CA 94563
Phone
(415) 750-2112
(925) 254-1866
(925) 254-1866
Personal information
See more information about WILLIAM MICHAEL KAVANAUGH at radaris.comName
Address
Phone
4232 Antelope Ct, Rocklin, CA 95677
9646 Lucerne Ave APT 202, Culver City, CA 90232
7832 Olive St, Fair Oaks, CA 95628
77 Orchard Rd, Orinda, CA 94563
1310 Crestview Ave, Seal Beach, CA 90740
Professional information
William Michael Kavanaugh, San Francisco CA
Specialties:
Internist
Address:
1650 Owens St, San Francisco, CA 94158
4150 Clement St, San Francisco, CA 94121
4150 Clement St, San Francisco, CA 94121
Education:
Vanderbilt University, School of Medicine - Doctor of Medicine
UCSF Medical Center - Fellowship - Cardiology
UCSF Medical Center - Residency - Internal Medicine
UCSF Medical Center - Fellowship - Cardiology
UCSF Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine)
William Michael Kavanaugh, San Francisco CA
Specialties:
Internal Medicine, Cardiovascular Disease, Cardiology, Surgery, Thoracic Surgery, Cardiothoracic Vascular Surgery
Work:
San Francisco Veterans Affairs Medical Center
4150 Clement St, San Francisco, CA 94121
4150 Clement St, San Francisco, CA 94121
Education:
Vanderbilt University (1983)
M-Csf-Specific Monoclonal Antibody And Uses Thereof
US Patent:
2010009, Apr 15, 2010
Filed:
Jul 27, 2006
Appl. No.:
11/996905
Inventors:
William M. Kavanaugh - Orinda CA, US
Lea Auckerman - Emeryville CA, US
Victoria Sung - Emeryville CA, US
Lea Auckerman - Emeryville CA, US
Victoria Sung - Emeryville CA, US
Assignee:
Novartis AG - Basel
XOMA Technology Ltd. - Hamilton
XOMA Technology Ltd. - Hamilton
International Classification:
A61K 39/395
US Classification:
4241331, 4241301, 4241411
Abstract:
M-CSF-specific RX1-based or RX-I derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in or remodeling in a subject afflicted with an osteoblastic or osteolytic disease.
Methods For Preventing And Treating Cancer Metastasis And Bone Loss Associated With Cancer Metastasis
US Patent:
2011009, Apr 21, 2011
Filed:
Aug 9, 2004
Appl. No.:
10/914598
Inventors:
William M. Kavanaugh - Orinda CA, US
Gregory M. Harrowe - Eugene OR, US
Kirston Koths - El Cerrito CA, US
Cheng Liu - Richmond CA, US
Deborah L. Zimmerman - Oakland CA, US
Gregory M. Harrowe - Eugene OR, US
Kirston Koths - El Cerrito CA, US
Cheng Liu - Richmond CA, US
Deborah L. Zimmerman - Oakland CA, US
International Classification:
A61K 39/395, A61P 35/00, A61P 19/08
US Classification:
4241331
Abstract:
M-CSF antagonists are used to prepare compositions, including pharmaceutical compositions, for preventing or treating cancer metastasis and/or bone loss associated with cancer metastasis in a mammal.
Method For Preventing And Treating Cancer Metastasis And Bone Loss Associated With Cancer Metastasis
US Patent:
2012004, Feb 23, 2012
Filed:
Aug 23, 2011
Appl. No.:
13/215683
Inventors:
William M. Kavanaugh - Orinda CA, US
Gregory M. Harrowe - Eugene OR, US
Kirston Koths - El Cerrito CA, US
Cheng Liu - Richmond CA, US
Deborah L. Zimmerman - Oakland CA, US
Gregory M. Harrowe - Eugene OR, US
Kirston Koths - El Cerrito CA, US
Cheng Liu - Richmond CA, US
Deborah L. Zimmerman - Oakland CA, US
Assignee:
NOVARTIS AG - Basel
International Classification:
A61K 39/395, A61P 35/00
US Classification:
4241581
Abstract:
M-CSF antagonists are used to prepare compositions, including pharmaceutical compositions, for preventing or treating cancer metastasis and/or bone loss associated with cancer metastasis in a mammal.
Soluble Human M-Csf Receptor And Uses Thereof
US Patent:
2014003, Jan 30, 2014
Filed:
Feb 20, 2013
Appl. No.:
13/771395
Inventors:
- Basel, CH
John Kunich - Orinda CA, US
William Michael Kavanaugh - Orinda CA, US
John Kunich - Orinda CA, US
William Michael Kavanaugh - Orinda CA, US
Assignee:
XOMA TECHNOLOGY LTD. - Berkeley CA
NOVARTIS AG - Basel
NOVARTIS AG - Basel
International Classification:
G01N 33/68
US Classification:
435 772, 435 792
Abstract:
Soluble human M-CSF receptor is provided, along with pharmaceutical compositions containing such receptor, kits containing a pharmaceutical composition, and methods of diagnosing and treating diseases and disorders associated with M-CSF such as bone loss in a subject afflicted with an osteolytic disease.
Uses Of Antibody To M-Csf
US Patent:
2008023, Sep 25, 2008
Filed:
Jul 27, 2006
Appl. No.:
11/996909
Inventors:
William M. Kavanaugh - Orinda CA, US
Assignee:
NOVARTIS AG - Basel
XOMA Technology Ltd. - Hamilton
XOMA Technology Ltd. - Hamilton
International Classification:
A61K 39/395, A61P 37/00
US Classification:
4241351, 4241721, 4241521, 4241331
Abstract:
Methods of using M-CSF antibodies to treat macrophage-associated diseases including atherosclerosis and HIV are provided.